Recombinant Photorhabdus luminescens subsp. laumondii 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase (mtnN)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
mtnN; plu0906; 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase; MTA/SAH nucleosidase; MTAN; EC 3.2.2.9; 5'-deoxyadenosine nucleosidase; DOA nucleosidase; dAdo nucleosidase; EC 3.2.2.-; 5'-methylthioadenosine nucleosidase; MTA nucleosidase; S-adenosylhomocysteine nucleosidase; AdoHcy nucleosidase; SAH nucleosidase; SRH nucleosidase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-233
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Photorhabdus luminescens subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01)
Target Names
mtnN
Target Protein Sequence
MKVGVIGAME QEVTLLRNQI EDRQTLSRGG CEIYTGKLNG VEIALLKSGI GKVSAAIGTT LLLEHCQPDV IINTGSAGGL DPKLQIGDIV VSREVRYHDT DVTAFGYEPG QMAQCPAAFV ADDQLIDLAE KCIHSLNLNA VRGLICSGDA FINGAEPLAR IRATFPQVTA VEMEAAAIGH VCHQYNTPFV VVRAISDVAD KESHISFDEF LAVAARQSTL MVNAMLATLS KDK
Uniprot No.

Target Background

Function
This enzyme catalyzes the irreversible cleavage of the glycosidic bond in both 5'-methylthioadenosine (MTA) and S-adenosylhomocysteine (SAH/AdoHcy), yielding adenine and the respective thioribose derivatives (5'-methylthioribose and S-ribosylhomocysteine). It also cleaves 5'-deoxyadenosine, a toxic byproduct of radical S-adenosylmethionine (SAM) enzymes, into 5-deoxyribose and adenine. This activity is essential for the in vivo function of radical SAM enzymes such as biotin synthase and lipoic acid synthase, which are inhibited by 5'-deoxyadenosine accumulation.
Database Links

KEGG: plu:plu0906

STRING: 243265.plu0906

Protein Families
PNP/UDP phosphorylase family, MtnN subfamily

Q&A

What is the function of 5'-Methylthioadenosine/S-Adenosylhomocysteine Nucleosidase in Photorhabdus luminescens?

5'-Methylthioadenosine/S-Adenosylhomocysteine Nucleosidase (mtnN, also referred to as MTN in some literature) is an enzyme responsible for the regulation and degradation of key nucleoside metabolites including 5'-Deoxyadenosine (5'dAdo), 5'-Methylthioadenosine (MTA), and S-adenosylhomocysteine (SAH). The enzyme plays a crucial role in cellular metabolism by preventing the accumulation of these metabolites, which would otherwise cause product inhibition of their respective synthetic pathways. In Photorhabdus luminescens, this enzyme is integral to maintaining proper cellular functions, particularly in metabolic pathways dependent on S-adenosylmethionine (SAM) .

How does mtnN activity relate to the pathogenicity of Photorhabdus luminescens?

The mtnN enzyme indirectly influences the pathogenicity of P. luminescens through its impact on quorum sensing and metabolic regulation. Deficiency in this enzyme results in elevated levels of 5'dAdo, MTA, and SAH, which leads to product inhibition of critical metabolic pathways. Accumulation of 5'dAdo specifically inhibits radical SAM-dependent vitamin synthesis, which is necessary for enzymes involved in central carbon metabolism. This metabolic disruption can affect the production of virulence factors, potentially altering the bacterium's ability to infect and kill insect hosts. Research with related bacterial systems has shown that interruption of MTN activity causes dramatic decreases in vitamin-dependent pyruvate dehydrogenase complex (PDHC) activity , which would significantly impact energy metabolism during infection processes.

What is the relationship between mtnN and bioluminescence in Photorhabdus luminescens?

While P. luminescens is known for producing luciferase, causing infected insect larvae to glow as they decay , the specific relationship between mtnN and bioluminescence involves metabolic regulation pathways. The enzyme's role in nucleoside metabolism influences quorum sensing pathways, which in turn regulate various phenotypes including bioluminescence. Research has demonstrated that quorum sensing molecules like autoinducer-2 (AI-2) modulate bioluminescence by regulating the synthesis of compounds such as spermidine . Since mtnN activity affects the metabolites involved in these regulatory networks, it indirectly influences the expression of genes responsible for bioluminescence in P. luminescens.

What are the optimal conditions for recombinant expression of P. luminescens mtnN?

For optimal recombinant expression of P. luminescens mtnN, researchers should consider a protocol similar to that used for related enzymes in the species. Based on established methods, the mtnN gene should be amplified and inserted into an expression vector such as pET-22b using appropriate restriction sites (NdeI and XhoI are commonly used). For protein production, E. coli BL21(DE3) containing a plasmid that synthesizes the lacI repressor (e.g., pDIA17) provides an effective expression system. Growth in nutrient-rich media such as Hyper Broth to an OD600 of approximately 3, followed by induction with 3 mM IPTG for 2 hours, has proven effective for related P. luminescens proteins . After centrifugation, bacterial pellets should be disrupted in an appropriate buffer (e.g., 20 mM sodium phosphate [pH 7.2] and 200 mM NaCl) using mechanical disruption methods such as a Fastprep apparatus.

How can researchers optimize protein yield when expressing recombinant P. luminescens mtnN?

To optimize recombinant P. luminescens mtnN yield, researchers should consider several critical factors. First, expression temperature plays a significant role, with growth at 28°C being optimal for Photorhabdus proteins due to the temperature sensitivity of this organism . Second, expression vector selection should incorporate strong, inducible promoters with appropriate fusion tags that enhance solubility without compromising enzymatic activity. Third, induction conditions should be optimized through testing various IPTG concentrations (1-5 mM) and induction times (2-24 hours). Finally, growth media composition significantly impacts yields, with rich formulations like Hyper Broth typically outperforming standard LB media . Researchers should conduct small-scale expression trials with different E. coli host strains (BL21, Rosetta, Arctic Express) to identify the optimal combination of these variables before scaling up production.

What purification strategies are most effective for recombinant P. luminescens mtnN?

The most effective purification strategy for recombinant P. luminescens mtnN typically involves a multi-step approach tailored to the enzyme's biochemical properties. If expressed with a hexahistidine tag, immobilized metal affinity chromatography (IMAC) using Ni-NTA resin provides an efficient first step, with elution using an imidazole gradient (50-300 mM). This should be followed by ion-exchange chromatography to separate the target protein from similarly charged contaminants, using either anion (Q-Sepharose) or cation (SP-Sepharose) exchange depending on the protein's isoelectric point. A final size-exclusion chromatography step (Superdex 75 or 200) ensures high purity and removes aggregates. Throughout purification, buffer conditions must be optimized to maintain enzyme stability, typically including 20-50 mM phosphate or Tris buffer (pH 7.0-8.0), 100-300 mM NaCl, and potentially 5-10% glycerol and 1-5 mM reducing agent (DTT or β-mercaptoethanol) to prevent oxidation of cysteine residues.

What are the most reliable methods for assaying mtnN enzymatic activity?

For reliable measurement of mtnN activity, several complementary methods can be employed. A spectrophotometric coupled assay is particularly effective, monitoring the formation of adenine at 265 nm as the enzyme catalyzes the hydrolysis of MTA or SAH. This approach requires careful control of experimental conditions and accounting for potential interferents. Alternatively, HPLC-based methods can directly quantify substrate consumption and product formation, offering greater specificity by separating reaction components chromatographically. For highest sensitivity, a radiometric assay using 14C- or 3H-labeled substrates allows detection of even low enzymatic activity. When designing these assays, researchers must consider the enzyme's temperature sensitivity, with optimal activity typically observed at 28-30°C for P. luminescens enzymes . The assay buffer composition is also critical, generally requiring pH 7.0-7.5 phosphate buffer supplemented with appropriate cofactors. Validation should include linear range determination, reproducibility assessment, and comparison with positive control enzymes from well-characterized organisms.

How does the kinetic behavior of recombinant mtnN differ from the native enzyme?

The kinetic behavior of recombinant mtnN may differ from the native enzyme in several key aspects. Recombinant expression can introduce structural modifications, particularly when fusion tags are employed, potentially altering substrate binding affinity (Km) or catalytic efficiency (kcat). When analyzing enzyme kinetics, researchers should employ appropriate modeling approaches, recognizing that simple Michaelis-Menten kinetics may not adequately describe the behavior of this enzyme. For more accurate analysis, particularly when dealing with multiple substrates or complex regulation, statistical approaches that account for the appropriate error structure are essential. While additive Gaussian noise is often assumed in enzyme kinetic models, a multiplicative log-normal error structure may better represent the true error distribution and prevent modeling artifacts such as negative reaction rates in simulations .

What is the temperature and pH profile of P. luminescens mtnN?

P. luminescens mtnN activity shows a distinctive temperature and pH profile reflecting the organism's ecological niche. Optimal enzymatic activity typically occurs at 28-30°C, corresponding to the bacterium's growth optimum. Activity decreases sharply above 35°C, consistent with the temperature restriction observed in P. luminescens growth . The enzyme typically exhibits a bell-shaped pH profile with maximum activity in the pH range of 7.0-7.5, typical of cytoplasmic enzymes. At pH extremes (below 5.0 or above 9.0), activity decreases dramatically due to protein structural changes affecting active site geometry. The temperature and pH dependencies should be characterized using standardized buffers with consistent ionic strength across the pH range to avoid buffer-dependent artifacts. When measuring temperature dependence, short incubation times should be employed to distinguish between temperature effects on reaction rate versus enzyme stability.

How can researchers design effective site-directed mutagenesis experiments to probe mtnN function?

When designing site-directed mutagenesis experiments to investigate P. luminescens mtnN function, researchers should adopt a systematic approach based on structural and functional analyses. First, identify conserved residues through multiple sequence alignment of mtnN from P. luminescens with homologs from related organisms. Second, utilize homology modeling or available crystal structures to predict critical catalytic and substrate-binding residues. Key targets should include residues directly involved in substrate binding, catalysis, or maintaining the active site architecture. Conservative mutations (e.g., Asp to Glu) can probe the importance of specific functional groups, while more drastic changes (e.g., Asp to Ala) can completely eliminate side chain contributions. After generating mutants, comprehensive kinetic characterization should include determination of Km and kcat values for each substrate, along with inhibition studies and pH-rate profiles to elucidate the role of each residue in catalysis. This approach allows researchers to construct a detailed mechanistic model of mtnN function and substrate specificity.

What strategies can be employed to study the in vivo role of mtnN in P. luminescens metabolism?

To study the in vivo role of mtnN in P. luminescens metabolism, researchers should employ a multi-faceted approach. First, generate a knockout mutant using homologous recombination or CRISPR-Cas9 techniques, confirmed by PCR and sequencing. Complement this with a strain expressing the gene under an inducible promoter to verify phenotypic restoration. Next, conduct comparative metabolomic analysis using LC-MS/MS to quantify changes in key metabolites, particularly 5'dAdo, MTA, and SAH, as well as downstream products affected by their accumulation. RNA-Seq or microarray analysis can identify transcriptional changes resulting from mtnN deletion, revealing affected pathways. Functional assays should measure activities of key metabolic enzymes, particularly those requiring vitamins synthesized through SAM-dependent pathways, similar to the PDHC activity studies in E. coli MTN knockouts . Additionally, investigate phenotypic changes in growth characteristics, stress response, pathogenicity against insect larvae, and symbiotic relationships with nematode hosts. Finally, conduct 13C-labeling experiments to trace carbon flux through central metabolic pathways, quantifying how mtnN deficiency redirects metabolic flow.

How does variation in nucleoside substrate structure affect mtnN catalytic efficiency?

The catalytic efficiency of P. luminescens mtnN varies significantly with nucleoside substrate structure, reflecting the enzyme's evolved specificity. To comprehensively characterize this relationship, researchers should synthesize or obtain a series of substrate analogs with systematic structural variations in the base, sugar, and thio-alkyl portions. Kinetic parameters (Km, kcat, and kcat/Km) should be determined for each substrate under standardized conditions. This structure-activity relationship study reveals which substrate features are critical for recognition and catalysis. Typically, modifications to the adenine base that alter hydrogen bonding capabilities significantly impact binding affinity, while alterations to the sugar moiety may affect proper orientation in the active site. The length and composition of the thio-alkyl chain often influence both binding and catalytic steps. Complementing kinetic studies with computational docking and molecular dynamics simulations can provide atomic-level insights into substrate recognition mechanisms. Isothermal titration calorimetry (ITC) further dissects binding energetics, separating enthalpic and entropic contributions to substrate affinity.

How can researchers overcome challenges in expressing active recombinant P. luminescens mtnN?

Researchers facing challenges with active recombinant P. luminescens mtnN expression should implement a systematic troubleshooting approach. For insoluble protein expression, lower the induction temperature to 16-20°C, reduce IPTG concentration (0.1-0.5 mM), and consider fusion partners that enhance solubility (SUMO, Thioredoxin, or MBP tags). For low expression levels, optimize codon usage for the host organism, particularly if rare codons are present in the mtnN sequence, or utilize specialized E. coli strains that supply rare tRNAs. If enzyme activity is suboptimal despite successful expression, verify the protein's folding state using circular dichroism spectroscopy and consider variations in purification protocols to minimize exposure to potentially denaturing conditions. The addition of specific cofactors or stabilizing agents (glycerol, trehalose) to purification buffers may preserve enzyme structure and function. Finally, co-expression with bacterial chaperones (GroEL/ES, DnaK/J) can facilitate proper folding of challenging proteins. A side-by-side comparison of multiple expression constructs with different fusion tags, host strains, and induction conditions often reveals the optimal combination for producing active enzyme.

What are the common pitfalls in designing inhibition studies for P. luminescens mtnN?

When designing inhibition studies for P. luminescens mtnN, researchers should be aware of several common pitfalls. First, ensure proper enzyme concentration selection—too high enzyme concentrations can mask inhibition through a phenomenon known as "enzyme titration," while too low concentrations may provide insufficient signal-to-noise ratios. Second, control for potential non-specific inhibition mechanisms such as aggregate formation by candidate inhibitors, which can be identified through the use of detergent controls or dynamic light scattering measurements. Third, carefully select the appropriate inhibition model (competitive, non-competitive, uncompetitive, or mixed) based on mechanistic considerations and validate through appropriate Lineweaver-Burk, Dixon, or more sophisticated non-linear regression analyses. Fourth, account for potential time-dependent inhibition, which may indicate a slow-binding or irreversible inhibition mechanism requiring modified experimental approaches. Finally, validate biochemical inhibition with cellular studies to confirm that the observed in vitro effects translate to the intended biological context, recognizing that cellular permeability, efflux mechanisms, and metabolic transformation can significantly alter inhibitor efficacy in vivo.

How should researchers interpret and troubleshoot contradictory data in mtnN functional studies?

When confronted with contradictory data in mtnN functional studies, researchers should implement a structured analytical approach. First, methodically review experimental conditions across studies, as variations in buffer composition, pH, temperature, or enzyme preparation can dramatically influence results. Create a comprehensive data comparison table highlighting key variables between experiments producing conflicting results. Second, consider the possibility of enzyme isoforms or post-translational modifications affecting activity; verify protein homogeneity using techniques such as mass spectrometry and native gel electrophoresis. Third, evaluate the sensitivity and limitations of each assay method; contradictions may arise from different detection methods having varying susceptibilities to interference. Fourth, examine statistical approaches used for data analysis, particularly the choice of error structure in enzyme kinetic models, as inappropriate assumptions can lead to systematic interpretation errors . Finally, design critical experiments specifically addressing the contradiction, isolating variables that may explain discrepancies. For instance, if substrate specificities differ between studies, conduct side-by-side comparisons using identical enzyme preparations and multiple analytical methods to definitively resolve the contradiction.

How can structural biology approaches enhance our understanding of P. luminescens mtnN?

Advanced structural biology approaches offer powerful tools for elucidating P. luminescens mtnN function at the molecular level. X-ray crystallography remains the gold standard, providing atomic-resolution structures of the enzyme in various states (apo, substrate-bound, product-bound, inhibitor-bound). These structures reveal critical insights into catalytic mechanisms, conformational changes during catalysis, and the structural basis of substrate specificity. Cryo-electron microscopy (cryo-EM) offers complementary information, particularly for visualizing conformational ensembles that may not crystallize. Solution-based techniques including small-angle X-ray scattering (SAXS) and hydrogen-deuterium exchange mass spectrometry (HDX-MS) can map dynamic regions and conformational changes under physiologically relevant conditions. For investigating dynamics on different timescales, nuclear magnetic resonance (NMR) spectroscopy and molecular dynamics simulations provide detailed views of protein motion relevant to catalysis. Integrating these complementary approaches creates a comprehensive structural model of mtnN function, enabling rational design of inhibitors and engineered variants with modified properties for biotechnological applications.

What role might P. luminescens mtnN play in developing novel bioinsecticides?

P. luminescens mtnN may serve as a significant target in developing novel bioinsecticides through several mechanisms. As a critical metabolic enzyme, mtnN inhibition could potentially attenuate virulence while preserving beneficial properties of P. luminescens for agricultural applications. Researchers should investigate whether selective chemical inhibition of mtnN modulates toxin production without eliminating the bacterium's ability to interact with plant roots, which has been identified as a potentially beneficial property for plant growth promotion . Another approach involves engineering P. luminescens strains with modified mtnN expression to optimize both insecticidal activity against target pests and beneficial interactions with plants. These dual-purpose strains could simultaneously control insect populations while promoting plant growth. Comparative studies of mtnN between P. luminescens and insect species could identify structural or functional differences that enable the development of inhibitors selectively targeting the insect enzyme, creating a new class of insecticides with minimal environmental impact. Finally, understanding mtnN's role in quorum sensing could allow manipulation of population-dependent behaviors critical for transitioning between mutualistic and pathogenic lifestyles.

How does temperature affect mtnN activity in the context of P. luminescens environmental adaptation?

Temperature significantly influences mtnN activity in P. luminescens, reflecting the bacterium's environmental adaptation mechanisms. While P. luminescens laboratory strains typically cannot grow above 35°C , the enzyme's temperature-activity profile provides insights into the molecular basis of this restriction. Researchers should investigate whether mtnN activity correlates with the temperature-dependent growth limitations, potentially through thermal stability studies using differential scanning calorimetry to determine melting temperatures (Tm) of wild-type and mutant enzymes. Temperature-dependent kinetic studies measuring activation energy (Ea) and thermodynamic parameters (ΔH‡, ΔS‡, ΔG‡) through Eyring plots can reveal the energetic barriers to catalysis at different temperatures. Of particular interest is whether naturally occurring P. luminescens strains with different temperature tolerances show variations in mtnN sequence or regulation that contribute to their adaptation to specific ecological niches. Comparative studies between mtnN from P. luminescens and homologs from thermotolerant bacteria might identify key structural features that influence thermal stability, potentially enabling protein engineering approaches to create temperature-adapted variants of the enzyme for biotechnological applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.